Maze Therapeutics (MAZE) Other financing activities (2024 - 2026)
Maze Therapeutics (MAZE) reported Other financing activities of $4.1 million for Q1 2026, down 96.81% on a YoY basis from $127.8 million in Q1 2025, and up 129.14% sequentially from -$14.0 million in Q4 2025.
Maze Therapeutics (MAZE) Other financing activities (2024 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 3 years of Other financing activities data on file, last reported at $4.1 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 96.81% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (down 96.82% YoY), and the FY2025 full-year result was $127.8 million, up 17328.65% from the prior year.
- Other financing activities grew to $4.1 million in Q1 2026, from -$14.0 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $127.8 million in Q1 2025 to a low of -$14.0 million in Q4 2025.
- A 3-year average of $16.6 million and a median of $295500.0 in 2024 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 34900.55% in 2025, while the deepest fall reached 22315.87% in 2025.
- Tracing MAZE's Other financing activities over 3 years: stood at $63000.0 in 2024, then slumped by 22315.87% to -$14.0 million in 2025, then soared by 129.14% to $4.1 million in 2026.
- Business Quant data shows MAZE's Other financing activities at $4.1 million in Q1 2026, -$14.0 million in Q4 2025, and $14.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.08 Mn |
| Mar 31, 2026 | 4.08 Mn |
| Dec 31, 2025 | -14.00 Mn |
| Dec 31, 2025 | -14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 127.75 Mn |
| Mar 31, 2025 | 127.75 Mn |
| Dec 31, 2024 | 63,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Mar 31, 2024 | 365,000.00 |